ArthroChip develops advanced diagnostics for autoimmune diseases. By examining gene signatures in peripheral blood, ArthroChip's strategy delivers distinct advantages over current tests. ArthroChip is working to produce several testing platforms based on this technology.

Initially targeting diagnosis of autoimmune disease, our long term goals include development of tests for allergic diseases, asthma and diabetes mellitus. Aside from testing for multiple diseases, ArthroChip is developing multiple platforms to address needs ranging from researchers to practicing physicians.